mRNA vaccines yielded not only strong short-term immune response against COVID-19, but also persistent immunity through at least 6 months, said a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
“This virus prompted fears of whether people developed adaptive immune response at all,” Shane Crotty, PhD, professor at the Center for Infectious Disease and Vaccine Research at the LaJolla Institute for Immunology in California. “[We started studying] this well before vaccines were developed at all.”
In his lab work, Crotty has spent significant